Some thoughts:
PYC's SP is in a positive trendline (PEACEAKKI, thanks) and the motivations for director's selling seems pretty straightforward, (thanks Andrew65).
With a recent low of around 5 cents, there are many recent buyers with a good reason to sell at over 7 cents. Just as these same folk see 8+ as too much of a leap to average up with.
So, for me, the recent (pre-good news) low of 5 cents is the real 'culprit' here, if there is one to name!
PYC has increased over 50% in 5 months and presents an excellent chart.
I see the determined retiree's selling as a great opportunity to buy at a discounted price to the actual de-risked new prospects of this company!
By de-risked I mean:
1. Frost and Sullivan Award,(Jan 2011)
2. Smallest MC in top 10 Bio-tech of the Year, (Jan 2011)
3. Funding finalised for re-vamped cash producing Perth lab, (Dec, 2010)
4. Big Pharma deals more transparently profitable for PYC short-term (various sources) 2011.
5. Big Pharma offer multiple (hundreds) of possible company-maker royalty generating compounds,
6. PYC established in industry in 'new-age' drug delivery (transport peptides for anti-biotic and anti-cancer drugs) research.
7. PYC deal with German pharma XL-protein GmbH for extending multiple drug classes 'half-life' (lower doses and lower side-effects) (Jan, 2011)
8. Astute management driving extremely lucrative contracts from a position of strength, in a unique biotech area where it's a 'seller's market'.
9. An established and increasing trend towards multiple contracts offering a cash-flow positive balance sheet for the foreseeable future.
10. The likelihood of multiple SP bumping good news over 11/12 and further international marketing magic yet to be exploited by recent (Dec/Jan) milestone announcements.
11. Multi-bagger takeover potential within 3 years.
Therefore, I see the 8 cent ceiling as a great opportunity to astutely accumulate at this time at these levels.
For these reasons, I believe all is on track for my money; although this stock is not for short-termies in the short term. Also, it's not for the impatient, or those with less than a 6 month investment churn strategy
The current eager selling around 7.7 - 8.3 cents represents a fantastic buying opportunity for a relatively ignored stock, still just below the horizon of the many would-be loyal fans.
A great buying opportunity for the confident, in a relatively ignored rising star IMHO
Good Luck to all: side-line sitters, holders, sellers and bottom drawers!
Positivity drives dreams.
PatrickM
- Forums
- ASX - By Stock
- PYC
- rising star
PYC
pyc therapeutics limited
Add to My Watchlist
2.51%
!
$1.36

rising star
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.36 |
Change
-0.035(2.51%) |
Mkt cap ! $793.2M |
Open | High | Low | Value | Volume |
$1.39 | $1.43 | $1.36 | $169.8K | 122.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 9675 | $1.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 2801 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 9675 | 1.360 |
2 | 11414 | 1.350 |
3 | 7878 | 1.340 |
1 | 692 | 1.300 |
1 | 196 | 1.275 |
Price($) | Vol. | No. |
---|---|---|
1.445 | 2801 | 1 |
1.450 | 16369 | 3 |
1.465 | 20000 | 1 |
1.470 | 16036 | 3 |
1.475 | 20000 | 1 |
Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online